Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Turnover | 46.07%345.72M | 37.44%654.48M | 44.46%236.68M | 70.46%476.21M | --163.83M | 59.47%279.36M | --175.17M |
| Operating income | 46.07%345.72M | 37.44%654.48M | 44.46%236.68M | 70.46%476.21M | 163.83M | 59.47%279.36M | 175.17M |
| Cost of sales | -44.63%-293.97M | -34.67%-549.71M | -35.35%-203.25M | -66.07%-408.18M | ---150.17M | -55.39%-245.79M | ---158.17M |
| Operating expenses | -44.63%-293.97M | -34.67%-549.71M | -35.35%-203.25M | -66.07%-408.18M | -150.17M | -55.39%-245.79M | -158.17M |
| Gross profit | 54.85%51.75M | 54.03%104.78M | 144.65%33.42M | 102.63%68.02M | 13.66M | 97.46%33.57M | 17M |
| Selling expenses | -66.74%-53.38M | 2.25%-71.1M | 3.33%-32.02M | -14.77%-72.74M | ---33.12M | -22.54%-63.37M | ---51.72M |
| Administrative expenses | -17.41%-58.94M | -43.87%-106.89M | -62.78%-50.2M | -35.65%-74.29M | ---30.84M | -20.49%-54.77M | ---45.45M |
| Research and development expenses | -50.23%-95.11M | -4.19%-156.11M | 22.21%-63.31M | -7.52%-149.83M | ---81.39M | -69.52%-139.35M | ---82.2M |
| Impairment and provision | -50.66%-9.94M | -270.31%-22.65M | -43.28%-6.6M | 18.64%-6.12M | ---4.6M | -242.30%-7.52M | ---2.2M |
| -Other impairment is provision | -50.66%-9.94M | -270.31%-22.65M | -43.28%-6.6M | 18.64%-6.12M | ---4.6M | -242.30%-7.52M | ---2.2M |
| Special items of operating profit | -63.20%3.22M | 0.69%29.46M | 119.99%8.76M | 164.37%29.26M | --3.98M | -57.31%11.07M | --25.92M |
| Operating profit | -47.71%-162.39M | -8.17%-222.5M | 16.91%-109.94M | 6.66%-205.69M | -132.3M | -58.95%-220.37M | -138.64M |
| Financing income | 205.09%5.09M | 15.56%2.27M | 64.60%1.67M | 59.40%1.97M | --1.01M | 482.08%1.23M | --212K |
| Financing cost | -31.94%-4.99M | -122.18%-7.49M | -150.46%-3.78M | -121.76%-3.37M | ---1.51M | -66.05%-1.52M | ---916K |
| Earning before tax | -44.84%-162.29M | -9.96%-227.72M | 15.63%-112.05M | 6.15%-207.1M | -132.8M | -58.35%-220.66M | -139.35M |
| Tax | ---- | 71.67%-17K | ---- | 65.12%-60K | ---33K | 61.78%-172K | ---450K |
| After-tax profit from continuing operations | -44.84%-162.29M | -9.94%-227.74M | 15.65%-112.05M | 6.19%-207.16M | -132.83M | -57.96%-220.83M | -139.8M |
| Earning after tax | -44.84%-162.29M | -9.94%-227.74M | 15.65%-112.05M | 6.19%-207.16M | -132.83M | -57.96%-220.83M | -139.8M |
| Minority profit | -174.19%-10.73M | -13.45%-11.25M | 44.12%-3.91M | -66.23%-9.92M | ---7M | 21.26%-5.97M | ---7.58M |
| Profit attributable to shareholders | -40.16%-151.56M | -9.76%-216.49M | 14.06%-108.14M | 8.20%-197.24M | -125.83M | -62.50%-214.86M | -132.22M |
| Basic earnings per share | -22.58%-0.38 | -3.39%-0.61 | 18.42%-0.31 | 10.61%-0.59 | -0.38 | -37.50%-0.66 | -0.48 |
| Diluted earnings per share | -22.58%-0.38 | -3.39%-0.61 | 18.42%-0.31 | 10.61%-0.59 | -0.38 | -37.50%-0.66 | -0.48 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.